MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now.
MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study. Subject review can begin within days.
"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM. "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."
Here is the link to the head to head comparison:
http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv
March 17, 2020
Topic Area: Press Release
Recent Posts
Seeking Standards for Microbial Loads in Healthcare Facilities
Why is there no binding standard for the acceptable microbial load on surfaces or in the air in hospitals?
UCR Health Unveils Plans for Major Expansion
The vision for the site will include an outpatient diagnostic center and possible future expansion.
High-Performance Windows Support Safety at UW Medicine's New Behavioral Health Center
Case study: Engineered for strength, quiet and daylight, the chosen windows help create a safe, calming and energy-efficient environment for patients and providers.
Central Maine Healthcare Dealing with IT System Outage
The organization identified unusual activity within their computer software, prompting them to secure and shut off all IT systems.
Kaiser Permanente Opens Newly Expanded Everett Medical Center
The facility offers primary care and pediatric care and has specialty care departments.